revasc
canyon pharmaceuticals ltd. - desuridine - veneuze trombose - antitrombotische middelen - preventie van diepe veneuze trombose bij patiënten die een electieve heup- of knievervangende operatie ondergaan.
anthelmex forte kauwtabletten voor honden
lavet pharmaceuticals ltd - febantel; praziquantel; pyrantelembonaat - kauwtablet - febantel 525 mg/stuk; praziquantel 175 mg/stuk; pyrantelembonaat 504 mg/stuk, - praziquantel, combinations - honden
anthelmex kauwtabletten voor honden
lavet pharmaceuticals ltd - febantel; praziquantel; pyrantelembonaat - kauwtablet - febantel 150 mg/stuk; praziquantel 50 mg/stuk; pyrantelembonaat 144 mg/stuk, - praziquantel, combinations - honden
dexsol 2mg/5 ml drank, drank
rosemont pharmaceuticals ltd. - dexamethasondinatriumfosfaat samenstelling overeenkomend met; dexamethason; - drank - dexamethasone
clobazam essential pharmaceuticals 1 mg/ml or. susp.
essential pharma (m) ltd. - clobazam 1 mg/ml - suspensie voor oraal gebruik - 1 mg/ml - clobazam 1 mg/ml - benzodiazepine derivatives
sutent
pfizer limited - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastische middelen - gastrointestinal stromal tumour (gist)sutent is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib mesilate treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression in adults. experience with sutent as first-line treatment is limited (see section 5.
oncept il-2
boehringer ingelheim vetmedica gmbh - vcp1338-virus - immunostimulants, antineoplastische en immunomodulerende middelen, immunostimulants, - cats - immunotherapie voor gebruik in combinatie met chirurgie en radiotherapie bij katten met fibrosarcoom (diameter 2-5 cm) zonder betrokkenheid van metastasen of lymfeklieren, om het risico van terugval te verminderen en de tijd tot terugval te verlengen (lokaal recidief of metastase).
quetiapine intas pharmaceuticals 50 mg tablet met verlengde afgifte
intas pharmaceuticals - quetiapinefumaraat - tablet met verlengde afgifte - 50 mg - quetiapinefumaraat 57.575 mg - quetiapine
quetiapine intas pharmaceuticals 200 mg tablet met verlengde afgifte
intas pharmaceuticals - quetiapinefumaraat - tablet met verlengde afgifte - 200 mg - quetiapinefumaraat 230.3 mg - quetiapine
quetiapine intas pharmaceuticals 300 mg tablet met verlengde afgifte
intas pharmaceuticals - quetiapinefumaraat - tablet met verlengde afgifte - 300 mg - quetiapinefumaraat 345.45 mg - quetiapine